Literature DB >> 2895346

Analgesic activity of morphine-6-glucuronide.

R Osborne, S Joel, D Trew, M Slevin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895346     DOI： 10.1016/s0140-6736(88)91691-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  59 in total

1.  Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue.

Authors:  A J Lawrence; G P Joshi; A Michalkiewicz; W P Blunnie; D C Moriarty
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation.

Authors:  M I Levene; M W Quinn
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

3.  Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.

Authors:  T J Wilkinson; B A Robinson; E J Begg; S B Duffull; P J Ravenscroft; J J Schneider
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.

Authors:  J J Schneider; P J Ravenscroft; J D Cavenagh; A M Brown; J P Bradley
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 5.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

6.  Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide.

Authors:  V Srinivasan; D Wielbo; J Simpkins; J Karlix; K Sloan; I Tebbett
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

Review 7.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

8.  Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations.

Authors:  J Hasselström; N Alexander; C Bringel; J O Svensson; J Säwe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

10.  Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration.

Authors:  H Quiding; G L Olsson; L O Boreus; U Bondesson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.